Cancer patients' experiences with medicinal cannabis-related care

被引:36
作者
Braun, Ilana M. [1 ,2 ,3 ]
Nayak, Manan M. [1 ,2 ,4 ]
Revette, Anna [2 ,5 ]
Wright, Alexi A. [2 ,6 ]
Chai, Peter R. [1 ,2 ,7 ,8 ]
Yusufov, Miryam [1 ,2 ,3 ]
Pirl, William F. [1 ,2 ,3 ]
Tulsky, James A. [1 ,2 ,9 ]
机构
[1] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, 450 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Phyllis F Cantor Ctr Res Nursing & Patient Care S, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Survey & Data Management Core, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA
[8] Fenway Inst, Boston, MA USA
[9] Brigham & Womens Hosp, Div Palliat Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
cannabis; complementary therapies; health communication; marijuana use; medical oncology; MEDICAL CANNABIS; PATTERNS;
D O I
10.1002/cncr.33202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Little is known about medical cannabis (MC)-related care for patients with cancer using MC. Methods Semistructured telephone interviews were conducted in a convenience sample of individuals (n = 24) with physician-confirmed oncologic diagnoses and state/district authorization to use MC (Arizona, California, Florida, Illinois, Massachusetts, Oregon, New York, and Washington, DC) from April 2017 to March 2019. Standard qualitative techniques were used to assess the degree of MC-related health care oversight, MC practices, and key information sources. Results Among 24 participants (median age, 57 years; range, 30-71 years; 16 women [67%]), MC certifications were typically issued by a professional new to a patient's care after a brief, perfunctory consultation. Patients disclosed MCuse to their established medical teams but received little medical advice about whether and how to use MC. Patients with cancer used MC products as multipurpose symptom management and as cancer-directed therapy, sometimes in lieu of standard-of-care treatments. Personal experimentation, including methodical self-monitoring, was an important source of MC know-how. Absent formal advice from medical professionals, patients relied on nonmedical sources for MC information. Conclusions Patients with cancer used MC with minimal medical oversight. Most received MC certifications through brief meetings with unfamiliar professionals. Participants desired but were often unable to access high-quality clinical information about MC from their established medical teams. Because many patients are committed to using MC, a product sustained by a growing industry, medical providers should familiarize themselves with the existing data for MM and its limitations to address a poorly met clinical need.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 22 条
[1]  
Allan GM, 2018, CAN FAM PHYSICIAN, V64, P111
[2]  
[Anonymous], 1990, Qualitative Evaluation and Research Methods
[3]   Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana [J].
Bostwick, J. Michael .
MAYO CLINIC PROCEEDINGS, 2012, 87 (02) :172-186
[4]   Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study [J].
Braun, I. M. ;
Meyer, F. L. ;
Gagne, J. J. ;
Nabati, L. ;
Yuppa, D. P. ;
Carmona, M. A. ;
Burstein, H. J. ;
Suzuki, J. ;
Nayak, M. M. ;
Martins, Y. .
PSYCHO-ONCOLOGY, 2017, 26 (08) :1087-1092
[5]   Reconciling the Discrepancies in Medicine's Relationship to Medical Marijuana [J].
Braun, Ilana ;
Tulsky, James .
ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) :646-+
[6]   Medical Oncologists' Views on the Utility of Medical Marijuana Across the Cancer Trajectory [J].
Braun, Ilana M. ;
Blonquist, Traci M. ;
Campbell, Eric G. ;
Nayak, Manan M. ;
Bolcic-Jankovic, Dragana ;
Wright, Alexi A. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (06) :E1-E4
[7]   Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study [J].
Braun, Ilana M. ;
Wright, Alexi ;
Peteet, John ;
Meyer, Fremonta L. ;
Yuppa, David P. ;
Bolcic-Jankovic, Dragana ;
LeBlanc, Jessica ;
Chang, Yuchiao ;
Yu, Liyang ;
Nayak, Manan M. ;
Tulsky, James A. ;
Suzuki, Joji ;
Nabati, Lida ;
Campbell, Eric G. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) :1957-1962
[8]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[9]  
Creswell J., 2017, Qualitative inquiry research design: Choosing among five approaches
[10]  
Green J, 2018, Qualitative methods for health research, V4th